Brief just-in-time multidisciplinary simulation-based intubation refresher training did not improve the resident's first attempt or overall tracheal intubation success.
Extracorporeal membrane oxygenation (ECMO) causes both thrombosis and bleeding. Major society guidelines recommend continuous, systemic anticoagulation to prevent thrombosis of the ECMO circuit, though this may be undesirable in those with active, or high risk of, bleeding. We aimed to systematically review thrombosis and bleeding outcomes in published cases of adults treated with ECMO without continuous systemic anticoagulation. Ovid MEDLINE, Cochrane CENTRAL and CDSR, and hand search via SCOPUS were queried. Eligible studies were independently reviewed by two blinded authors if they reported adults (≥18 years) treated with either VV- or VA-ECMO without continuous systemic anticoagulation for ≥24 hours. Patient demographics, clinical data, and specifics of ECMO technology and treatment parameters were collected. Primary outcomes of interest included incidence of bleeding, thrombosis of the ECMO circuit requiring equipment exchange, patient venous or arterial thrombosis, ability to wean off of ECMO, and mortality. Of the 443 total publications identified, 34 describing 201 patients met our inclusion criteria. Most patients were treated for either acute respiratory distress syndrome or cardiogenic shock. The median duration of anticoagulant-free ECMO was 4.75 days. ECMO circuity thrombosis and patient thrombosis occurred in 27 (13.4%) and 19 (9.5%) patients, respectively. Any bleeding and major or “severe” bleeding was reported in 66 (32.8%) and 56 (27.9%) patients, respectively. Forty patients (19%) died. While limited by primarily retrospective data and inconsistent reporting of outcomes, our systematic review of anticoagulant-free ECMO reveals an incidence of circuity and patient thrombosis comparable to patients receiving continuous systemic anticoagulation while on ECMO.
Background
Social interaction can serve as a natural reward that attenuates drug
reward in rats; however, it is unknown if age or housing conditions alter
the choice between social interaction and drug.
Methods
Individually- and pair-housed adolescent and adult rats were tested
using conditioned place preference (CPP) in separate experiments in which:
(1) social interaction was conditioned against no social interaction; (2)
amphetamine (AMPH; 1 mg/kg, s.c.) was conditioned against saline; or (3)
social interaction was conditioned against AMPH.
Results
Social interaction CPP was obtained only in individually-housed
adolescents, whereas AMPH CPP was obtained in both individually-housed
adolescents and adults; however, the effect of AMPH was not statistically
significant in pair-housed adults. When allowed to choose concurrently
between compartments paired with either social interaction or AMPH,
individually-housed adolescents preferred the compartment paired with social
interaction, whereas pair-housed adolescents preferred the compartment
paired with AMPH. Regardless of housing condition, adults showed a similar
preference for the compartments paired with either social interaction or
AMPH.
Conclusions
Although some caution is needed in interpreting cross-experiment
comparisons, the overall results suggest that individually-housed
adolescents were most sensitive to the rewarding effect of social
interaction, and this hypersensitivity to social reward effectively competed
with AMPH reward.
It is feasible to rate the technical and behavioral performance of multidisciplinary airway management teams during real intensive care unit intubation events by using our assessment tool. The presence of two or more multidisciplinary simulation-trained providers is associated with improved performance during real events.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.